VERICEL CORPORATION Net Cash Provided by (Used in) Continuing Operations
VERICEL CORPORATION (VCEL) reported Net Cash Provided by (Used in) Continuing Operations of -$8.58 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2019-02-26
- VERICEL CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was -$3.13M.
- VERICEL CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2016-12-31 was $14.10M.
- VERICEL CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2016-09-30 was -$955.00K.
- VERICEL CORPORATION net cash provided by (used in) continuing operations for the quarter ending 2016-06-30 was -$3.71M.
- VERICEL CORPORATION net cash provided by (used in) continuing operations for fiscal 2018 was -$8.58M, a 320.80% decline from fiscal 2017.
- VERICEL CORPORATION net cash provided by (used in) continuing operations for fiscal 2017 was $3.88M, a 53.75% decline from fiscal 2016.
- VERICEL CORPORATION net cash provided by (used in) continuing operations for fiscal 2016 was $8.40M.
- VERICEL CORPORATION net cash provided by (used in) continuing operations for fiscal 2015 was -$15.76M, a 170.73% decline from fiscal 2014.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month | Net Cash Provided by (Used in) Continuing Operations 270 month | Net Cash Provided by (Used in) Continuing Operations 273 month | Net Cash Provided by (Used in) Continuing Operations 276 month | Net Cash Provided by (Used in) Continuing Operations 279 month | Net Cash Provided by (Used in) Continuing Operations 282 month | Net Cash Provided by (Used in) Continuing Operations 285 month | Net Cash Provided by (Used in) Continuing Operations 288 month | Net Cash Provided by (Used in) Continuing Operations 291 month | Net Cash Provided by (Used in) Continuing Operations 294 month | Net Cash Provided by (Used in) Continuing Operations 297 month | Net Cash Provided by (Used in) Continuing Operations 300 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | -$8.58M 10-K · filed 2019-02-26 | ||||||||||||||
| 2017-12-31 | $3.88M 10-K · filed 2019-02-26 | ||||||||||||||
| 2017-03-31 | -$3.13M 10-Q · filed 2017-05-10 | $10.97M derived: sum of 2 quarters · filed 2019-02-26 | $10.01M derived: sum of 3 quarters · filed 2019-02-26 | $6.30M derived: sum of 4 quarters · filed 2019-02-26 | |||||||||||
| 2016-12-31 | $14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $13.14M derived: sum of 2 quarters · filed 2019-02-26 | $9.43M derived: sum of 3 quarters · filed 2019-02-26 | $8.40M 10-K · filed 2019-02-26 | |||||||||||
| 2016-09-30 | -$955.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$4.66M derived: sum of 2 quarters · filed 2016-11-07 | -$5.70M 10-Q · filed 2016-11-07 | -$9.84M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||
| 2016-06-30 | -$3.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$4.75M 10-Q · filed 2016-08-08 | -$8.89M derived: sum of 3 quarters · filed 2018-03-05 | -$10.38M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||
| 2016-03-31 | -$1.04M 10-Q · filed 2017-05-10 | -$5.18M derived: sum of 2 quarters · filed 2018-03-05 | -$6.67M derived: sum of 3 quarters · filed 2018-03-05 | -$12.36M derived: sum of 4 quarters · filed 2018-03-05 | |||||||||||
| 2015-12-31 | -$4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | -$5.64M derived: sum of 2 quarters · filed 2018-03-05 | -$11.32M derived: sum of 3 quarters · filed 2018-03-05 | -$15.76M 10-K · filed 2018-03-05 | |||||||||||
| 2015-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | -$7.18M derived: sum of 2 quarters · filed 2016-11-07 | -$11.62M 10-Q · filed 2016-11-07 | -$18.85M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2015-06-30 | -$5.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$10.13M 10-Q · filed 2016-08-08 | -$17.36M derived: sum of 3 quarters · filed 2017-03-13 | $12.96M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2015-03-31 | -$4.44M 10-Q · filed 2016-05-10 | -$11.68M derived: sum of 2 quarters · filed 2017-03-13 | $18.64M derived: sum of 3 quarters · filed 2017-03-13 | $17.07M derived: sum of 4 quarters · filed 2017-03-13 | |||||||||||
| 2014-12-31 | -$7.24M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $23.08M derived: sum of 2 quarters · filed 2017-03-13 | $21.51M derived: sum of 3 quarters · filed 2017-03-13 | $22.28M 10-K · filed 2017-03-13 | |||||||||||
| 2014-09-30 | $30.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $28.74M derived: sum of 2 quarters · filed 2015-11-13 | $29.52M 10-Q · filed 2015-11-13 | $26.76M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | -$796.00K 10-Q · filed 2015-08-12 | -$3.55M derived: sum of 3 quarters · filed 2016-03-14 | $2.77M derived: sum of 4 quarters · filed 2016-03-14 | |||||||||||
| 2014-03-31 | $777.00K 10-Q · filed 2015-05-14 | -$1.98M derived: sum of 2 quarters · filed 2016-03-14 | $4.34M derived: sum of 3 quarters · filed 2016-03-14 | -$390.00K derived: sum of 4 quarters · filed 2016-03-14 | $8.84M 10-Q · filed 2014-05-15 | ||||||||||
| 2013-12-31 | -$2.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $3.56M derived: sum of 2 quarters · filed 2016-03-14 | -$1.17M derived: sum of 3 quarters · filed 2016-03-14 | -$5.58M 10-K · filed 2016-03-14 | $8.06M 10-K · filed 2014-03-13 | ||||||||||
| 2013-09-30 | $6.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $1.59M derived: sum of 2 quarters · filed 2014-11-13 | -$2.82M 10-Q · filed 2014-11-13 | -$10.27M derived: sum of 4 quarters · filed 2015-03-25 | $10.82M 10-Q · filed 2013-11-12 | ||||||||||
| 2013-06-30 | -$4.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$9.14M 10-Q · filed 2014-08-14 | -$16.59M derived: sum of 3 quarters · filed 2015-03-25 | -$24.17M derived: sum of 4 quarters · filed 2015-03-25 | $4.49M 10-Q · filed 2013-08-07 | ||||||||||
| 2013-03-31 | -$4.41M 10-Q · filed 2014-05-15 | -$11.86M derived: sum of 2 quarters · filed 2015-03-25 | -$19.44M derived: sum of 3 quarters · filed 2015-03-25 | -$27.51M derived: sum of 4 quarters · filed 2015-03-25 | $9.23M 10-Q · filed 2013-05-08 | ||||||||||
| 2012-12-31 | -$7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-25 | -$15.03M derived: sum of 2 quarters · filed 2015-03-25 | -$23.09M derived: sum of 3 quarters · filed 2015-03-25 | $8.11M 10-K · filed 2015-03-25 | $13.64M 10-K · filed 2013-03-18 | ||||||||||
| 2012-09-30 | -$7.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$15.64M derived: sum of 2 quarters · filed 2013-11-12 | $15.56M 10-Q · filed 2013-11-12 | $9.14M derived: sum of 4 quarters · filed 2014-03-13 | $21.09M 10-Q · filed 2012-11-08 | ||||||||||
| 2012-06-30 | -$8.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $23.14M 10-Q · filed 2013-08-07 | $16.72M derived: sum of 3 quarters · filed 2014-03-13 | $10.14M derived: sum of 4 quarters · filed 2014-03-13 | $28.67M 10-Q · filed 2012-08-07 | ||||||||||
| 2012-03-31 | $31.20M 10-Q · filed 2013-05-08 | $24.79M derived: sum of 2 quarters · filed 2014-03-13 | $18.21M derived: sum of 3 quarters · filed 2014-03-13 | $12.11M derived: sum of 4 quarters · filed 2014-03-13 | $36.73M 10-Q · filed 2012-05-10 | ||||||||||
| 2011-12-31 | -$6.42M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$12.99M derived: sum of 2 quarters · filed 2014-03-13 | -$19.09M derived: sum of 3 quarters · filed 2014-03-13 | -$25.72M 10-K · filed 2014-03-13 | $5.53M 10-K · filed 2012-03-15 | ||||||||||
| 2011-09-30 | -$6.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$12.67M derived: sum of 2 quarters · filed 2012-11-08 | -$19.30M 10-Q · filed 2012-11-08 | $11.95M 10-Q · filed 2011-11-08 | |||||||||||
| 2011-06-30 | -$6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$12.73M 10-Q · filed 2012-08-07 | |||||||||||||
| 2011-03-31 | -$6.63M 10-Q · filed 2012-05-10 | ||||||||||||||
| 2010-12-31 | $17.13M 10-K · filed 2013-03-18 | ||||||||||||||
| 2010-09-30 | -$273.00K 10-Q · filed 2011-11-08 | ||||||||||||||
| 2010-06-30 | -$2.88M 10-K · filed 2013-03-18 | ||||||||||||||
| 2009-06-30 | $508.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |